Could Ozempic save you from a heart attack?
May 14, 2024•18 min
Listen to this episode in Metacast mobile app
Don't just listen to podcasts. Learn from them with transcripts, summaries, and chapters for every episode. Skim, search, and bookmark insights. Learn more
Episode description
Anti-obesity jabs like Ozempic could reduce the risk of heart attacks, strokes or heart failure in obese people regardless of the amount of weight they lose while on the drug.
Researchers found after three years of treatment participants had a 20% lower risk of obesity and its associated health impacts, which currently cost the NHS over £6bn per year.
On the Sky News Daily, Niall Paterson speaks to Sky’s science and medical correspondent Thomas Moore about the implications of reducing heart disease cases for the NHS, and senior lecturer in physiology at Anglia Ruskin University Dr Simon Cork explains how the wonder-drug actually works.
Producer: Emma Rae Woodhouse
Podcast Promotions Producer: David Chipakupaku
Editor: Philly Beaumont
Researchers found after three years of treatment participants had a 20% lower risk of obesity and its associated health impacts, which currently cost the NHS over £6bn per year.
On the Sky News Daily, Niall Paterson speaks to Sky’s science and medical correspondent Thomas Moore about the implications of reducing heart disease cases for the NHS, and senior lecturer in physiology at Anglia Ruskin University Dr Simon Cork explains how the wonder-drug actually works.
Producer: Emma Rae Woodhouse
Podcast Promotions Producer: David Chipakupaku
Editor: Philly Beaumont
For the best experience, listen in Metacast app for iOS or Android